---
{"dg-publish":true,"permalink":"/research/takeaways/a-urolithin-a-dose-of-at-least-4-mg-kg-day-may-reduce-the-progression-of-ivd-degeneration/"}
---

# Assumptions
<div><ul class="dataview list-view-ul"></ul></div>

# Supporting Insights
<div><ul class="dataview list-view-ul"><li><span><a data-tooltip-position="top" aria-label="Research/Insights/Urolithin A reduces the progression of IVD degeneration at a dose of 25 mg-kg-day when taken for 4 weeks after an IVD puncture at 8 weeks of age compared to rats not fed urolithin A.md" data-href="Research/Insights/Urolithin A reduces the progression of IVD degeneration at a dose of 25 mg-kg-day when taken for 4 weeks after an IVD puncture at 8 weeks of age compared to rats not fed urolithin A.md" href="Research/Insights/Urolithin A reduces the progression of IVD degeneration at a dose of 25 mg-kg-day when taken for 4 weeks after an IVD puncture at 8 weeks of age compared to rats not fed urolithin A.md" class="internal-link" target="_blank" rel="noopener" fileclass-name="Research Links">Urolithin A reduces the progression of IVD degeneration at a dose of 25 mg-kg-day when taken for 4 weeks after an IVD puncture at 8 weeks of age compared to rats not fed urolithin A</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></li><li><span><a data-tooltip-position="top" aria-label="Research/Insights/A urolithin A dose of 25 mg-kg-day in a rat equates to 4 mg-kg-day in a human.md" data-href="Research/Insights/A urolithin A dose of 25 mg-kg-day in a rat equates to 4 mg-kg-day in a human.md" href="Research/Insights/A urolithin A dose of 25 mg-kg-day in a rat equates to 4 mg-kg-day in a human.md" class="internal-link" target="_blank" rel="noopener" fileclass-name="Research Links">A urolithin A dose of 25 mg-kg-day in a rat equates to 4 mg-kg-day in a human</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></li><li><span><a data-tooltip-position="top" aria-label="Research/Insights/Urolithin A reduces the progression of IVD degeneration at a dose of 25 mg-kg-day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A.md" data-href="Research/Insights/Urolithin A reduces the progression of IVD degeneration at a dose of 25 mg-kg-day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A.md" href="Research/Insights/Urolithin A reduces the progression of IVD degeneration at a dose of 25 mg-kg-day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A.md" class="internal-link" target="_blank" rel="noopener" fileclass-name="Research Links">Urolithin A reduces the progression of IVD degeneration at a dose of 25 mg-kg-day when taken for 4 weeks after an IVD puncture at 4-6 months of age compared to rats not fed urolithin A</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></li></ul></div>

# Original Sources
<div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Source</span><span class="dataview small-text">3</span></th><th class="table-view-th"><span>Citation Key</span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span>Shi, Peng-Zhi, Jun-Wu Wang, Ping-Chuan Wang, Bo Han, Xu-Hua Lu, Yong-Xin Ren, Xin-Min Feng, Xiao-Fei Cheng, and Liang Zhang. “Urolithin a Alleviates Oxidative Stress-Induced Senescence in Nucleus Pulposus-Derived Mesenchymal Stem Cells through SIRT1/PGC-1α Pathway.” World Journal of Stem Cells 13, no. 12 (December 26, 2021): 1928–46. <a rel="noopener" class="external-link" href="https://doi.org/10.4252/wjsc.v13.i12.1928" target="_blank">https://doi.org/10.4252/wjsc.v13.i12.1928</a>.</span></td><td><span><a data-tooltip-position="top" aria-label="Research/Evidence Sources/shiUrolithinAlleviatesOxidative2021.md" data-href="Research/Evidence Sources/shiUrolithinAlleviatesOxidative2021.md" href="Research/Evidence Sources/shiUrolithinAlleviatesOxidative2021.md" class="internal-link" target="_blank" rel="noopener" fileclass-name="Research Links">shiUrolithinAlleviatesOxidative2021</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td></tr><tr><td><span>USFDA. “Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers.” FDA, December 1, 2018. <a rel="noopener" class="external-link" href="https://www.fda.gov/regulatory-information/search-fda-guidance-documents/estimating-maximum-safe-starting-dose-initial-clinical-trials-therapeutics-adult-healthy-volunteers" target="_blank">https://www.fda.gov/regulatory-information/search-fda-guidance-documents/estimating-maximum-safe-starting-dose-initial-clinical-trials-therapeutics-adult-healthy-volunteers</a>.</span></td><td><span><a data-tooltip-position="top" aria-label="Research/Evidence Sources/usfdaEstimatingMaximumSafe2018.md" data-href="Research/Evidence Sources/usfdaEstimatingMaximumSafe2018.md" href="Research/Evidence Sources/usfdaEstimatingMaximumSafe2018.md" class="internal-link" target="_blank" rel="noopener" fileclass-name="Research Links">usfdaEstimatingMaximumSafe2018</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td></tr><tr><td><span>Lin, Jialiang, Jinru Zhuge, Xuanqi Zheng, Yuhao Wu, Zengjie Zhang, Tianzhen Xu, Zaher Meftah, et al. “Urolithin A-Induced Mitophagy Suppresses Apoptosis and Attenuates Intervertebral Disc Degeneration via the AMPK Signaling Pathway.” Free Radical Biology &amp; Medicine 150 (April 2020): 109–19. <a rel="noopener" class="external-link" href="https://doi.org/10.1016/j.freeradbiomed.2020.02.024" target="_blank">https://doi.org/10.1016/j.freeradbiomed.2020.02.024</a>.</span></td><td><span><a data-tooltip-position="top" aria-label="Research/Evidence Sources/linUrolithinAinducedMitophagy2020.md" data-href="Research/Evidence Sources/linUrolithinAinducedMitophagy2020.md" href="Research/Evidence Sources/linUrolithinAinducedMitophagy2020.md" class="internal-link" target="_blank" rel="noopener" fileclass-name="Research Links">linUrolithinAinducedMitophagy2020</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td></tr></tbody></table></div>

# Database Fields